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Viral envelope versus Env glycoproteins
The final step of virion release from retrovirus-infected cells consists of the coating of viral cores that contain the viral-encoded enzymes and the dimeric RNA viral genome surrounded by capsid proteins. This step occurs through budding and egress of viral particles at the cell surface and provides virions with an envelope that is constituted by a plasma membrane-derived lipid bilayer enriched in viral envelope glycoproteins (Env) .
As is the case for all infectious retroviruses, HTLV Env derives from an envelope polyprotein precursor that is cleaved by cellular proteases yielding a mature Env that is inserted into the viral envelope ( Figure 1 ). Env is composed of a surface amino terminal component (SU) and a transmembrane carboxy terminal component (TM) . SU is entirely extracellular and in the case of the prototypic MT-2 strain of HTLV-1, it is composed of 288 amino acids (not including the 20 amino-acid signal peptide that is cleaved during Env translation) with 4 N-glycosylation sites (Delamarre et al., 1996) and an apparent mass of 46 kDa (gp46). SU is associated, most likely via labile disulfide bonds, to the membraneanchored TM which is 180 amino acid long with one N-glycosylation site and an apparent mass of 21 kDa (gp21). Like all retroviral TM, HTLV-1 TMgp21 harbors an amino terminal fusion peptide ( Figure 1 ).
Productive retrovirus infections, leading to the formation of viral progeny as opposed to nonproductive cell attachment and entry, appear to proceed only via interactions between virion-harbored Env molecules and specific cellular receptors present at the cell surface. It is generally accepted that those receptors, leading to either pH-independent direct fusion of the viral envelope at the plasma membrane or pH-dependent fusion within endocytic vesicles, constitute selective ports of entry for infectious particles. In the case of nonlentiviral mammalian retroviruses, virus entry has been thoroughly studied in different models, including mouse and feline leukemia viruses (MLV, FeLV) . For these latter viruses, productive Env-mediated entry can be schematically described as the binding of an amino terminal receptor binding domain (RBD) in the SU to a cell surface receptor, leading to conformational changes that unmask the TM fusion peptide and initiate a membrane fusion process.
Receptors versus viral entry receptors
Contacts between viruses and cells also occur outside of the bona fide Env-receptor interactions that lead to productive viral replication. In the absence of either viral Env or a receptor for viral entry, virions are likely to attach to cells and enter before degradation in phagosome-like structures (Marechal et al., 1998 (Marechal et al., , 2001 . The crossing of the mucosal epithelial barrier by HIV has been proposed as another example of retrovirus entry into a cell wherein it will not replicate. Virions traverse from the cell apical lumen side to the basolateral side by transcytosis, before release to heterologous cells (Bomsel, 1997) . Transcytosis occurs via an interaction between Env and glycosphyngolipids that are harbored by the epithelial cells (Hocini and Bomsel, 1999) . Another physiologically important situation that does not seem to depend on binding to the receptor for virus entry involves dendritic cells (DC). DC can be used by several pathogens to escape immune surveillance but can also serve as carriers from the primary exposed mucosal site to target organs (Ludwig et al., 2004) . The transport of HIV virions by DC and their subsequent presentation to lymphoid targets seems to require Env-mediated virion binding to a DC-specific lectin, the intercellular adhesion molecule (ICAM)-3 grabbing non-integrin (DC-SIGN) (Geijtenbeek and van Kooyk, 2003; Steinman et al., 2003) . Nevertheless, transmission to lymphocytes several days after the initial exposure of DC to HIV requires Env-mediated virus entry and minimal viral replication (Nobile et al., 2005) . Similarly, both the integrin lymphocyte functionassociated antigen 1 (LFA-1), via its interaction with ICAM-1 incorporated in HIV envelope (Fortin et al., 1997) , and the heparan sulfate proteoglycan syndecan, via a direct interaction with the HIV-1 SU (gp120) (Bobardt et al., 2003) , have been shown to favor adsorption of HIV and SIV particles and enhance transmission to target cells.
Whether the nonproductive engulfing or transport of virions, described for HIV and other retroviral as well as nonretroviral pathogens, play a role in HTLV infection remains unknown. Nevertheless, it is important to note that the examples depicted above involve cell receptors that preferentially interact with virions, in an Envdependent or independent manner. These receptors should be distinguished from cell receptors that mediate viral entry and production of a new viral progeny.
Cell type-specific pathogenesis versus tropism
Viral tropism is regularly used to describe cell populations that either express viral products or are subjected to a cytopathic viral effect. In the absence of further precision, those uses may be misleading. From a strictly virological perspective, viral tropism refers to all cell types in which virus entry leads to the production of viral progeny, or cell types that maintain this production potential with 'dormant' viruses. As for all retroviruses, this is of particular importance in the context of HTLV, due to the stable integration of the viral genome in infected cells including T lymphocytes, whose in vivo lifespan may exceed a decade (Muul et al., 2003) . Pathogenic effects are thus additional properties, that obviously depend directly on cell tropism but that, strictly speaking, do not participate in its definition.
Env binding to a cell surface receptor is the first hurdle for the establishment of an infection, and as such Env/receptor binding constitutes a cornerstone of viral tropism. However, completion of the retroviral replication cycle also depends on numerous postbinding events and cell factors whose influence can drastically impact on infection outcome and hence tropism, independent of cell surface receptors. One classical example of a postbinding factor limiting cell tropism has been described for the T-cell tropic strain of the mammalian feline leukemia retrovirus (FeLV-T), whose Env receptor is the inorganic phosphate transporter PiT1 (see Table 1 ). Briefly, infection by FeLV-T is restricted to cells expressing the cat T-cell-encoded FeLIX glycoprotein, and as such the virus productively infects only T lymphocytes in vivo , although PiT1 is expressed in most tissues. Another block in the retroviral cycle has been elucidated due to the inability of HIV to replicate in mouse cells that are made fully permissive to viral entry. The block in this case is located after integration and caused by the inability of the mouse cyclin T1 to form a functional complex with HIV Tat (Bieniasz et al., 1998) . Several other preintegration and postbinding/post-entry blocks limiting retroviral tropism have been identified for several retroviruses (Nisole and Saib, 2004) . Nevertheless, although envelope-independent restriction factors have been shown to play a role in the low infectivity of cell-free HTLV-1 virions (Derse et al., 2001) , the identities of such factors have yet to be elucidated.
The apparent in vivo tropism of a virus can be drastically skewed by the variables of a natural infection. Thus, parameters that alter the availability and accessibility of potential target cells, due to the Figure 1 Cell-to-cell transmission of HTLV. HTLV particles bud from GLUT1-positive infected cells in areas of the cell membrane enriched for the viral envelope glycoprotein (Env). HTLV particles bind to GLUT1 on target cells via the Env receptor-binding domain (RBD) located in the SU. Binding to GLUT1 is most likely followed by conformational changes that involve the proline-rich region (PRR), between the SU RBD and carboxy terminus (C-term), leading to the unmasking of the fusion peptide located in the Env transmembrane component (TM) and penetration of the viral core in the cytoplasm HTLV-1 envelope and its receptor GLUT1 N Manel et al route and dose of the initial viral exposure, age at infection, status of the immune response, genetic background, etc., will play a major role in the tissue distribution of the virus. Additionally, combined viral and hosts properties that specifically reduce (via viral cytopathic effects, immune clearance, necrosis or apoptosis) or expand (via mitogenic and transforming effects) certain infected cell compartments will also considerably alter the apparent tropism. In the case of most retroviruses, which combine lytic, transforming and inflammatory pathogenic effects, the impact of these processes on the observed tropism are likely be magnified.
HTLV-1 tropism: in vitro or in vivo veritas?
In vitro and in vivo tropism of HTLV-1 Studies documenting in vitro infection and dissemination of HTLV-1 to non-T cells, including nonlymphoid cells, were published soon after the identification of HTLV (Yamamoto et al., 1982b; Clapham et al., 1983; Hayami et al., 1984) . Productive transmission of natural HTLV-1 isolates to primary human endothelial cell cultures (Ho et al., 1984; Hoxie et al., 1984) , monocyte and microglial cells (Hoffman et al., 1992) , as well as basal mammary epithelial cells (LeVasseur et al., 1998) has been reported.
In vivo, HTLV-1 is readily detected in CD4 þ T lymphocytes in both asymptomatic and symptomatic carriers ( (Grant et al., 2002) and references therein), thus making it clear that the CD4 þ cell compartment constitutes a privileged component of the in vivo HTLV-1 tropism (Richardson et al., 1990) . Nevertheless, this crucial observation and the quasi-exclusive association of in vivo HTLV-1-induced proliferation to the CD4 þ T cell compartment has tended to diminish, if not obliterate, the in vivo tropism of HTLV-1 in many other cell types. Indeed, many earlier reports published in the mid 1980s described the potential infection of B lymphocytes by HTLV-1 in vivo (Yamamoto et al., 1982a; Longo et al., 1984; Franchini et al., 1985) . However, because of a step of in vitro culture, in vitro infection by contaminating HTLV þ T cells could not be formally excluded. In 1993, Koyanagi et al. (1993) thoroughly explored the in vivo infection by HTLV-1 in different hematopoietic cell compartments and in the absence of in vitro culture. Using PCR and RT-PCR to detect Tax DNA and RNA, they demonstrated that although the highest numbers of HTLV-1 DNA proviral copies and active transcription were generally found in CD4 þ T lymphocytes, most asymptomatic HTLV-1-infected individuals, as well as HAM/TSP and ATL patients also exhibited infection of CD8 þ lymphocytes, monocytes and B lymphocytes (Koyanagi et al., 1993) (in vivo infection of nonhematopoietic tissues was not addressed: Y Koyanagi, personal communication) . Interestingly, these authors also described an ATL patient in transient remission with no detectable HTLV-1 DNA in CD4 þ cells, even though CD8 þ cells, B cells and monocytes were infected. Others reports have largely confirmed the in vivo infection of HTLV-1 in CD8 þ cells (Eiraku et al., 1998; Hanon et al., 2000; Nagai et al., 2001; Grant et al., 2002) and references therein. Accordingly, under certain conditions, the in vitro transformation of unselected PHA-treated peripheral blood lymphocytes by coculture with an irradiated HTLV-infected cell line can lead to a vast majority of CD8 þ transformants (N Taylor, unpublished results). HTLV-1 envelope and its receptor GLUT1 N Manel et al
The search for HTLV sequences by in situ hybridization, in post-mortem brains of HAM/TSP patients has demonstrated that astrocytes can also be productively infected (Lehky et al., 1995) . Documented in vivo infection of noncultured adherent cells remains rare but has occasionally been reported in sweat gland epithelia (Setoyama et al., 1998 (Setoyama et al., , 1999 , salivary glands (Tangy et al., 1999) , vascular endothelial cells (Setoyama et al., 1998) and mammary glands (Loureiro et al., 2000) .
In conclusion, although the CD4 þ T-cell compartment appears to be the overwhelming reservoir, maintaining HTLV-1 infection during the lifespan of an infected individual, other hematopoietic cells (non-CD4 þ T cell subsets, B lymphocytes, monocytes and macrophages, dendritic cells and megakariocytes) as well as glial cells (astrocytes and microglial cells) are also part of the HTLV-1 in vivo tropism (Macatonia et al., 1992; Koyanagi et al., 1993; Lehky et al., 1995; Levin et al., 1997; Eiraku et al., 1998; Hanon et al., 2000; Nagai et al., 2001; Grant et al., 2002) .
Animal models: a broad in vivo tropism
Following the discovery of HTLV-1, several groups have developed rodent models of HTLV-1 infection (see Lairmore and Ratner, this issue). Thus, rabbit (Akagi et al., 1985; Zhao et al., 2002) , rat (Suga et al., 1991; Ishiguro et al., 1992) and mouse (Fang et al., 1998; Tanaka et al., 2001 ) models of persistent HTLV-1 infection have been reported. In all these models, HTLV-1 was detected in a large spectrum of hematopoietic cell types and nonhematopoietic tissues, including brain, lung, kidney, heart, liver, thyroid, as well as thymic and endometrium epithelia, depending on the model and the timing of the inoculation.
HTLV-1 infection and spreading has also been closely examined after intravenous inoculation of adult squirrel monkeys (Saimiri sciureus) (Kazanji et al., 1997 (Kazanji et al., , 2000 Mortreux et al., 2001) . In this model, peripheral blood mononuclear cells were the main infected cell compartment, but other HTLV-1-infected tissues including salivary and thyroid glands, lung, liver, pancreas, intestine, muscle and spinal cord were sporadically detected in individual monkeys (Kazanji et al., 2000) .
HTLV-1 envelope glycoprotein and receptor

HTLV-1: a complex deltaretrovirus with a simple gammaretrovirus type Env
The human HTLV and simian STLV retroviruses are deltaretroviruses that belong to the 'complex' retrovirus family, along with lentiviruses and spumaviruses, characterized by double spliced RNAs that code for regulatory proteins. Notably though, alignment of the HTLV-1 SU with that of the Friend-murine leukemia virus (F-MLV) reveals highly conserved microdomains within the SU and underscores a similar general organization of the SU (Kim et al., 2000 (Kim et al., , 2004a (Figure 2) . Functional evaluation of different SU domains, as delineated in Figure 2 , allowed us to demonstrate that, paradoxically to its 'complex' genetic organization, the HTLV SU has a modular organization that is identical to that of simple retroviruses (Battini et al., 1995) , with the RBD residing at the SU amino terminal (Kim et al., 2000 (Kim et al., , 2004b . Furthermore, we found that this domain was sufficient for receptor binding, as measured by FACS analysis, fusion, infection and interference to infection (Kim et al., 2000 (Kim et al., , 2004b , and did not require the central proline-rich region (PRR) of HTLV Env to exert these properties (Kim et al., 2000 (Kim et al., , 2004b .
The HTLV receptor enigma
Early studies on the HTLV-1 Env receptor Since the identification and isolation of HTLV-1 in the early 1980s, numerous efforts have been undertaken to identify its cellular receptor. It was rapidly shown by Env interference to superinfection that HTLV-1 and -2 (Clapham et al., 1984) and related simian isolates (Sommerfelt and Weiss, 1990) share the same receptor. However, the search for a receptor was hampered by the combination of (i) a widely expressed receptor among vertebrate cell lines, (ii) an Env-mediated rampant syncytial effect and (iii) an inability to produce high titering cell-free virions.
In the quest for tools to help the identification of an HTLV-1 receptor, two human liver cell lines (Okuma were reported as lacking detectable expression of HTLV Env receptor or as being resistant to HTLV-1 Envmediated pseudotype entry. However, it must be noted that binding of a tagged HTLV-1 SU to MDBK cells is significant, albeit at low levels .
Receptor detection assays Three main categories of read-outs have been used exclusively or in combination to evaluate the availability of functional HTLV receptors: (i) Infection with heterologous nonretroviral (Clapham et al., 1984; Sommerfelt et al., 1988; Sommerfelt and Weiss, 1990) or retroviral (Sutton and Littman, 1996; Trejo and Ratner, 2000; Manel et al., 2003a) virions pseudotyped with HTLV-1 Env. An adaptation of this assay consists of the substitution of the HTLV-1 env gene for that of the VSV-G transmembrane protein into the VSV genome (Okuma et al., 2003) . (ii) Cell-to-cell fusion mediated by HTLV-1 Env. Fusion is generally measured by the formation of multinucleated giant syncytial cells (Hoshino et al., 1983; Hildreth et al., 1997; Tajima et al., 1997) , or by an adaptation of an HIV Tat-based assay (Rocancourt et al., 1990) in which Env-receptor interactions are revealed by the transfer of HIV Tat molecules to indicator cells harboring a Tat-dependent marker gene (Denesvre et al., 1995) . The latter appears more suited to directly evaluate receptor function, since several cell lines that are fully susceptible to HTLV-1 Env-mediated viral entry are resistant to syncytia formation (Kim et al., 2003) . (iii) Binding of HTLV-1 Env, or RBDcontaining Env derivatives, to receptor-harboring cells. The first version of these assays used whole tagged virions (Gavalchin et al., 1993) , while more refined versions rely on binding of either HTLV-1 SU fused to an immunoadhesin , or the isolated RBD as a diversely tagged soluble protein (Manel et al., 2003a, b; Kim et al., 2004b) .
HTLV receptor and coreceptor candidates
Earlier suggestion that chromosome 17 encodes an HTLV-1 receptor, based on mouse cells resistance, has been abandoned. Thus, mouse cell lines are readily susceptible to HTLV Env-mediated binding , membrane fusion (Denesvre et al., 1995) and retroviral infection (Trejo and Ratner, 2000) .
Several groups have explored the identification of cell surface factors that influence HTLV Env-mediated receptor interactions, by measuring HTLV-1 Envinduced syncytia formation. Tetraspanins, which are promiscuous proteins that interact with many membrane components, including integrins, have been reported to both positively and negatively affect syncytia formation (Imai et al., 1992; Pique et al., 2000) .
The influence of ICAM and their integrin receptors in HTLV infection and pathophysiology has also emerged (Uchiyama et al., 1996; Hildreth et al., 1997; Al-Fahim et al., 1999; Daenke et al., 1999; Daenke and Booth, 2000) . VCAM-1 has been reported to stimulate HTLV-1 Env-mediated syncytia, an event that is specifically blocked by an anti-HTLV SU antibody, independently of VLA-4, the integrin that binds VCAM-1 (Hildreth et al., 1997) . Others have reported an effect of integrins binding ICAM-1 and -3 in the production of syncytia mediated by HTLV-1 Env and an inhibition of this effect by antibodies directed against beta integrins (Daenke et al., 1999; Daenke and Booth, 2000) . Antibodies directed against GPI-anchored proteins (Niyogi and Hildreth, 2001) or class II histocompatibility molecules (Hildreth, 1998) have been found to specifically block HTLV-1-induced syncytia formation, likely by steric hindrance within lipid rafts (Niyogi and Hildreth, 2001) . Using similar approaches, Sagara et al. (1998 Sagara et al. ( , 2001 ) have identified a membrane-associated HSC70 heat-shock cognate protein, as well as beta actin and a phosphatidyl glycerol, as parts of membrane structures wherein HTLV-induced syncytia formation proceeds.
Heparan sulfate proteoglycans (HSPG) are polyanionic-sulfated carbohydrate chains that branch a multitude of proteins at the cell membrane or in the extracellular matrix (Spillmann, 2001) . They have been shown to bind and favor attachment and subsequent receptor-mediated entry of numerous enveloped and nonenveloped viruses, including human and animal herpes simplex viruses, flaviviruses, picornaviruses (Spillmann, 2001) and HIV (Bobardt et al., 2003) . The presence of HSPG at the cell surface also influences HTLV-1 Env-mediated binding and viral entry (Okuma et al., 2003; Pinon et al., 2003) , whereas cholesterol seems to play a role at a postbinding level (Wielgosz et al., 2005) .
HTLV Env peptide mapping experiments were performed to identify functional determinants in the HTLV envelope (Sagara et al., 1996) . A peptide corresponding to SU amino acid 197 to 216 (P197) was found to inhibit HTLV-1 Env-induced cell-cell fusion. This region lies in the PRR central domain (Figure 2 ), which is recognized by neutralizing antibodies (Ralston et al., 1989; Goetz et al., 1997) , suggesting that this region is important for fusion to proceed. Based on these data, P197 was considered to mirror the HTLV Env receptor domain. However, neutralizing antibodies that block viral entry do not necessarily map to the Env RBD and may interfere by steric hindrance with fusion and syncytia formation at a postbinding step. This is the case, for instance, of the 83A25 neutralizing monoclonal antibody which recognizes a murine leukemia virus Env epitope in the SU carboxyterminus, at the opposite side of the RBD, downstream of the PRR (Evans et al., 1990) . Indeed, it has since been shown that peptide P197 does not compete with the cell binding properties of the HTLV-1 SU , indicating that this region is likely to be mostly important for postbinding events as previously shown for its MLV counterpart (Lavillette et al., 1998) . The mechanism by which P197 and anti-P197 antibodies inhibit fusion activity is unclear and possible nonexclusive mechanisms include blocking of the Env in a transitional conformation, alterations of interactions between Env HTLV-1 envelope and its receptor GLUT1 N Manel et al molecules or interference with additional cellular factors that may play a role in postbinding viral entry steps. From the studies mentioned above, it is therefore possible to draw the following sequence of events leading to HTLV-1 Env-mediated entry: (i) Attachment and increased mobilization of HTLV particles at the target cell surface via attachment to extracellular matrix structures such as HSPG, most likely in the context of cell-to-cell interactions (Igakura et al., 2003; Jolly and Sattentau, 2004) . (ii) Env interaction with a high-affinity receptor favored by attachment, followed by conformational changes that unmask the fusion peptide and direct entry in a structure compatible with productive infection; (iii) Formation or sequestration of virions within such structures of the plasma membrane, within or in the vicinity of lipid rafts, where fusion and viral entry can proceed.
Mammalian gammaretroviruses use nutrient transporters as receptors Gammaretrovirus receptors identified to date are either multimembrane-spanning nutrient transporters or, for those of unknown function, have a structure that is compatible with nutrient transport functions (Tailor et al., 2003) (Table 1 ). The closely related structural organization of HTLV and gammaretrovirus Env (Figure 2 ) led us to predict that the HTLV receptor would also be a member of this family of molecules (Kim et al., 2000) . Basyuk et al. (2003) have previously shown that MLV Env redirects endogenous retroviral RNA-Gag trafficking from intracellular lysosomes to exiting endosomes. Based on these observations and several phylogenetic considerations on the dichotomy between the evolutionary pattern of retroviral env genes and the remainder of the retroviral genome (Malik et al., 2000; Benit et al., 2001; Pearson and Rohrmann, 2002; Kim et al., 2004a) , we have postulated that infectious gammaretroviruses emerged upon env gene 'capture' by endogenous retrotransposons (Kim et al., 2004a) . Thus, it is possible that upon 'capture' of an env gene, intracellular interactions between Env and its cell receptor foster the routing of the virus out of the cell (Kim et al., 2004a) . Therefore, evaluating the contribution of Env-receptor interactions in viral egress might provide additional clues on the exclusive selection by gammaretroviruses and HTLV of nutrient transporters as Env receptors (Tailor et al., 2003) .
GLUT1, the HTLV Env receptor
As described in Kim et al. (2004b) , we were able to derive RBD-containing truncated domains of HTLV-1 and -2 SU as soluble amino terminal-tagged fusion proteins (HRBD). As expected for a bona fide receptor binding ligand, HRBD exerted full interfering abilities with exogenous HTLV Env. Thus, HTLV-1 and -2 Env binding, as well as Env-mediated cell-free and cell-to-cell infection were specifically blocked in HRBD-expressing cells, while remaining fully susceptible to MLV Envmediated binding and infection (Kim et al., 2004b) .
The elucidation of the modular structure of HTLV-1 Env, the subsequent production of HRBD-derived tagged constructs and two key observations that we made while monitoring receptor expression with those tools led us to the identification of the HTLV Env receptor.
The first observation was paradoxical with regards to the importance of T-cell infection in HTLV pathophysiology. Indeed, we (Manel et al., 2003b) , using HRBD constructs, and others using an entire SU (Nath et al., 2003) , observed no or little expression of the HTLV Env receptor in freshly isolated peripheral blood mononuclear cells, including CD4 þ T cells. This a priori puzzling result was elucidated by the observation that T-cell receptor activation of both memory and naı¨ve T cells led to the rapid emergence, within 4-6 h, of cell surface HTLV receptor expression on CD4 þ as well as CD8 þ T lymphocytes (Manel et al., 2003b; Nath et al., 2003) . Therefore, increased expression of the receptor at cell surface is an early marker of T lymphocyte activation, a feature that has most likely contributed to the receptor selection by HTLV. Moreover, in vitro activation of other hematopoietic populations was also associated with an HTLV receptor upregulation (Nath et al., 2003) .
The second observation was that introduction of HRBD by transfection into cultured cell lines block acidification of the cell culture milieu, as visualized by the persistence of a red tint in phenol red-containing culture supernatants (Manel et al., 2003a) . Proton enrichment from cultured vertebrate cell lines is largely due to the joint transport of protons with lactate as a glycolysis by-product. After experimentally excluding the potential role for widely distributed proton-linked lactacte transporters (MCT) and the MCT-associated CD147 protein (Kirk et al., 2000) as receptors for HTLV Env ( (Manel et al., 2003a) and unpublished observations), we focused on glucose transport, which fuels glycolysis. These studies quickly centered on GLUT1, the most largely distributed and conserved glucose transporter (Mueckler, 1994) .
GLUT1 is a 12 membrane-spanning passive facilitator of glucose transport across the cell surface (Figure 3a) . GLUT1 expression reflects intense metabolic activity, and its overexpression is used as a detection marker for numerous tumors (Smith, 1998; Younes et al., 1996) . Moreover, GLUT1, in accordance with the known properties of the HTLV Env receptor, is expressed on all evaluated mammalian cell lines. Indeed, in vivo proliferation of tumors as well as ex vivo culture of cell lines are characterized by a switch from respiration to lactate fermentation, and as such have an increased requirement for glucose. Notably though, GLUT1 appears to be the mandatory glucose transporter used by mammalian cells cultured ex vivo via traditional methods.
We have shown that GLUT1 fulfills all characteristics of a retrovirus receptor (Manel et al., 2003a) , among which are the ability to directly interact with HTLV envelopes, mediate infection by viral surrogates harboring the HTLV envelope, and specifically alleviate HTLV Env viral interference to superinfection (Manel et al., 2003a) . Others have confirmed that GLUT1 increases HTLV infection in the relatively resistant MDBK cells (Coskun and Sutton, 2005) . Furthermore, using GLUT1 and GLUT3 chimeric molecules, we identified the binding domain for HTLV envelopes on GLUT1, as well as separate domains required for subsequent viral entry (Manel et al., 2005) .
Following our identification of GLUT1 as the HTLV receptor, it was important to reassess data on HTLV receptor expression with results obtained by direct studies of GLUT1 (for a review, see Manel et al., 2004) . This was particularly of interest in the context of CD4 þ T lympocytes, the major in vivo HTLV reservoir. Indeed, as we and others reported for the as yet unknown HTLV receptor, GLUT1 is not detectable on resting lymphocytes and is a major marker of active lymphocyte metabolism (Chakrabarti et al., 1994; Frauwirth et al., 2002) . Moreover, TCR engagement of naı¨ve and memory T cells (Manel et al., 2003b; Nath et al., 2003) and TGF-b-induced signaling of neonatal T lymphocytes rapidly induce GLUT1 expression at the cell surface, as measured with HTLV SU-derived ligands. Finally, it is notable that the homeostatic cytokine IL-7 induces surface GLUT1 expression on neonatal T cells to a significantly higher level than on adult T cells, as assessed by HRBD binding. This difference has biological significance as IL-7-induced neonatal T cells have a significantly increased glucose uptake as compared to their equivalently treated adult counterparts (S Kinet and N Taylor, unpublished observations). The combined increase in surface GLUT1 and metabolic activity are likely to be crucial for propagating HTLV infection following mother-to-infant transmission of this virus.
Conclusions and perspectives
Our recent mapping of distinct determinants on GLUT1 that play separate roles in binding and postbinding steps of HTLV Env-mediated infection provides additional tools to elucidate a few of the enigmas surrounding HTLV-1 infection, dissemination and pathophysiology. It will thus be of interest to evaluate the sequence of events that involve GLUT1 and Env in the context of promiscuous factors promoting virus attachment, such as HSPG or ICAMs, as well as candidate coreceptors (D Ghez, Y Lepelletier, C Pique and O Hermine, personal communication).
It is also interesting that GLUT1 appears to concentrate in viral synapses (unpublished results of D Brighty cited in Jolly and Sattentau (2004) ) such as those formed between HTLV-1-infected and noninfected lymphocytes (Igakura et al., 2003) . Accordingly, we have noted that GLUT1 molecules that are present at the cell surface tend to concentrate at regions of cell contact, even in the absence of HTLV Env (Figure 3b) .
Despite the fact that tropism depends on many parameters that are independent of Env-receptor interactions, the discovery of GLUT1 as an HTLV receptor reinforces the notion of a broader in vivo tropism than usually perceived and provides additional clues to the pathophysiology associated with HTLV-1 infections (Manel et al., 2004) . Thus, other tissues where GLUT1 is expressed include the endothelial bloodbrain barrier, notably the luminal membrane (Cornford et al., 1994) , and various cell types of the eye, including the ganglion cell layer of the retina, the endothelium lining the canal of Schlemm, the corneal endothelium and the basal cells of the corneal epithelium (Kumagai et al., 1994) . It will be important to explore whether this diverse expression of GLUT1 in the eye is related with the development of HTLV-associated uveitis (Mochizuki et al., 1996) .
Additionally, GLUT1 is expressed in glial cells of the central nervous system (Kumagai et al., 1994; Virgintino et al., 1997) . In the peripheral blood, GLUT1 is detected primarily at the surface of red blood cells, where it accounts for up to 5% of the total content in membrane protein (Mueckler, 1994) . Therefore, potential Env One enlightening example centers on the importance of GLUT1 in the metabolic exchanges between intracerebral vessels and nerve terminals via glial cells in general and astrocytes in particular Voutsinos-Porche et al., 2003; Bonvento et al., 2005) . Indeed, the privileged anatomical relationship between astrocyte endfeet that project into the vasculature and individual endothelial cells of the blood-brain barrier (Kacem et al., 1998) provide tracks to explore in HTLV-associated neuropathophysiological effects. Ex vivo studies of interactions between these different cell types placed in the presence of HTLV-1 or different types of HTLV-1-infected cells will help a better understanding of HTLV spreading and pathology. Altogether, the in vitro and in vivo observations and the different animal models of infection indicate that HTLV-1 spreads among many cell types in vivo, with a preponderance of CD4 þ T cells (Grant et al., 2002) . The specific elimination of infected CD8 þ cells (Hanon et al., 2000) , as well as the elimination, counterselection or nonproductive infection (Lehky et al., 1995; Levin et al., 1997; Grant et al., 2002) of HTLV-1-infected non-CD4 þ cells is likely to minimize the detectable spectrum of HTLV-1 tropism in vivo. More sensitive and noninvasive methods of detection (Yamano et al., 2002; Heams and Kupiec, 2003; Spivack et al., 2004) should further future studies of HTLV-1 expression in situ. Potential in vivo application of these methods to the early and systematic follow-up of nonhematopoietic epithelial and endothelial tissues, in different contexts of HTLV-1 infection, is likely to provide a more precise depiction of the in vivo HTLV-1 tropism.
